Clinical trial
Efficacy and Safety of Fosrenol in Treating Elevated Serum Phosphate Levels in…
NCT00160121 · Shire, Industry · Completed
Key facts
| NCT number | NCT00160121 |
|---|---|
| Title | Efficacy and Safety of Fosrenol in Treating Elevated Serum Phosphate Levels in Adults With End Stage Renal Disease |
| Official title | A Phase IV, Open-Label, Multi-Center Trial Evaluating the Efficacy of Fosrenol Compared to Existing Therapy in Adults With End Stage Renal Disease Treated for Hyperphosphatemia |
| Lead sponsor | Shire, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Kidney Failure, Chronic |
| Intervention type | Drug |
| Interventions | Lanthanum carbonate |
| Enrollment | 2,500 |
| Start date | Jan 10, 2005 |
| Primary completion | Dec 13, 2005 |
| Completion | Dec 13, 2005 |
| First posted | Sep 12, 2005 |
| Last update posted | Jul 2, 2021 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: